PET/MRI: Where might it replace PET/CT?
暂无分享,去创建一个
Thomas A. Hope | Soonmee Cha | Andrew P. Leynes | S. Cha | J. Villanueva-Meyer | G. Johnson | T. Hope | P. Larson | E. Ehman | Javier E. Villanueva‐Meyer | Eric C. Ehman | Geoffrey B. Johnson | Andrew Palmera Leynes | Peder Eric Zufall Larson
[1] Andrew P. Leynes,et al. Hybrid ZTE/Dixon MR‐based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI , 2017, Medical physics.
[2] K. Hergan,et al. Erratum to: Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series , 2017, Journal of Nuclear Cardiology.
[3] O. Akin,et al. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma , 2017, Clinical nuclear medicine.
[4] K. Hergan,et al. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series , 2018, Journal of Nuclear Cardiology.
[5] G. Antoch,et al. Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT? , 2017, European Radiology.
[6] Michael Forsting,et al. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT. , 2016, European journal of radiology.
[7] M. Schwaiger,et al. Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. , 2016, European urology.
[8] O. Sabri,et al. Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. , 2016, Oral oncology.
[9] A. Buck,et al. Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction , 2016, The Journal of Nuclear Medicine.
[10] A. Wetter,et al. Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI , 2016, PloS one.
[11] Yi Su,et al. Impact of MR-Based Attenuation Correction on Neurologic PET Studies , 2016, The Journal of Nuclear Medicine.
[12] B. Bijan,et al. Comparison of different functional imaging modalities including FDG PET/CT and DWI-MRI with respect to their value in TNM staging of cholangiocarcinoma. , 2016 .
[13] Sirong Chen,et al. Response prediction in HCC patients treated with 90Y glass microspheres based on metabolic parameters: post-radioembolization 90Y PET/CT tumor dose and pretreatment 11C-acetate & 18F-FDG PET/CT metobolic grading , 2016 .
[14] A. Wetter,et al. Comparative Performance of 18F-FDG PET/MRI and 18F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients , 2016, The Journal of Nuclear Medicine.
[15] R. Laforest,et al. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma , 2016, Pediatric Radiology.
[16] Gaspar Delso,et al. Design Features and Mutual Compatibility Studies of the Time-of-Flight PET Capable GE SIGNA PET/MR System , 2016, IEEE Transactions on Medical Imaging.
[17] C. Dodge,et al. Assessment of Sequential PET/MRI in Comparison With PET/CT of Pediatric Lymphoma: A Prospective Study. , 2016, AJR. American journal of roentgenology.
[18] Tyler J. Fraum,et al. PET/MRI: Emerging Clinical Applications in Oncology. , 2016, Academic radiology.
[19] A. Buck,et al. Evaluation of Atlas-Based Attenuation Correction for Integrated PET/MR in Human Brain: Application of a Head Atlas and Comparison to True CT-Based Attenuation Correction , 2016, Journal of Nuclear Medicine.
[20] B. Rosen,et al. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients , 2016, Abdominal Radiology.
[21] G. Delso,et al. Zero TE MR bone imaging in the head , 2016, Magnetic resonance in medicine.
[22] N. Schwenzer,et al. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to 18F-Fluorodeoxyglucose Positron Emission Tomography/Compu , 2016, Investigative radiology.
[23] G. V. von Schulthess,et al. TNM Staging of Non–Small Cell Lung Cancer: Comparison of PET/MR and PET/CT , 2016, The Journal of Nuclear Medicine.
[24] Gerald Antoch,et al. Evaluation of the Outcome of Lung Nodules Missed on 18F-FDG PET/MRI Compared with 18F-FDG PET/CT in Patients with Known Malignancies , 2016, The Journal of Nuclear Medicine.
[25] J. Lee,et al. Added Value of Integrated Whole-Body PET/MRI for Evaluation of Colorectal Cancer: Comparison With Contrast-Enhanced MDCT. , 2016, AJR. American journal of roentgenology.
[26] C. Tzavara,et al. Incremental prognostic value of MRI in the staging of early cervical cancer: a prospective study and review of the literature. , 2016, Clinical imaging.
[27] Kevin M. Johnson,et al. Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET/MR System. , 2016, Radiology.
[28] C. Levin,et al. Design Features and Mutual Compatibility Studies of the Time-of-Flight PET Capable GE SIGNA PET/MR System. , 2016, IEEE transactions on medical imaging.
[29] B. Sheu,et al. Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole‐body PET/MR: Correlation with pathological prognostic factors , 2015, Journal of magnetic resonance imaging : JMRI.
[30] Peter B Sachs,et al. Lung CT Screening Reporting and Data System Speed and Accuracy Are Increased With the Use of a Semiautomated Computer Application. , 2015, Journal of the American College of Radiology : JACR.
[31] Michael Forsting,et al. Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT. , 2015, European journal of radiology.
[32] H. Goldschmidt,et al. Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma. , 2015, American journal of nuclear medicine and molecular imaging.
[33] M. Forsting,et al. Integrated PET/MRI for whole-body staging of patients with primary cervical cancer: preliminary results , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[34] H. Quick,et al. Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR reading. , 2015, European journal of radiology.
[35] G. Hermosillo,et al. Whole-Body PET/MR Imaging: Quantitative Evaluation of a Novel Model-Based MR Attenuation Correction Method Including Bone , 2015, The Journal of Nuclear Medicine.
[36] A. Scarsbrook,et al. FDG PET/CT in infection and inflammation--current and emerging clinical applications. , 2015, Clinical radiology.
[37] Yasheng Chen,et al. MR-based attenuation correction for PET/MRI neurological studies with continuous-valued attenuation coefficients for bone through a conversion from R2* to CT-Hounsfield units , 2015, NeuroImage.
[38] S. Hain,et al. Value of Gallium-68 Dotatate PET Scan in staging patients with appendiceal carcinoid tumour: a case series. , 2015 .
[39] K. Yaddanapudi,et al. PET-MRI in diagnosing pedal osteomyelitis in diabetic patients , 2015 .
[40] H. Zaidi,et al. Impact of Time-of-Flight PET on Quantification Errors in MR Imaging–Based Attenuation Correction , 2015, The Journal of Nuclear Medicine.
[41] H. Chandarana,et al. PET/MRI for the evaluation of patients with lymphoma: initial observations. , 2015, AJR. American journal of roentgenology.
[42] S. Matsumoto,et al. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. , 2015, Radiology.
[43] Garry Gold,et al. Simultaneous Whole-Body Time-of-Flight 18F-FDG PET/MRI: A Pilot Study Comparing SUVmax With PET/CT and Assessment of MR Image Quality , 2015, Clinical nuclear medicine.
[44] P. Christian,et al. Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom , 2015, The Journal of Nuclear Medicine.
[45] M. Essler,et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[46] M. Roethke,et al. Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[47] Gerald Antoch,et al. Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[48] Koichi Nagata,et al. Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT. , 2014, World journal of gastroenterology.
[49] D. Jeyarajah,et al. MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”? , 2014, Journal of Gastrointestinal Surgery.
[50] Felix Nensa,et al. Clinical applications of PET/MRI: current status and future perspectives. , 2014, Diagnostic and interventional radiology.
[51] Jaap Stoker,et al. Whole‐body MRI, including diffusion‐weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study , 2014, Journal of magnetic resonance imaging : JMRI.
[52] O. Sabri,et al. Potential Pediatric Applications of PET/MR , 2014, The Journal of Nuclear Medicine.
[53] M. Forsting,et al. Correlation of Standardized Uptake Value and Apparent Diffusion Coefficient in Integrated Whole-Body PET/MRI of Primary and Recurrent Cervical Cancer , 2014, PloS one.
[54] P. Heusch,et al. Thoracic Staging in Lung Cancer: Prospective Comparison of 18F-FDG PET/MR Imaging and 18F-FDG PET/CT , 2014, The Journal of Nuclear Medicine.
[55] F. Bengel,et al. Advanced Imaging of Cardiac Sarcoidosis , 2014, The Journal of Nuclear Medicine.
[56] M. Forsting,et al. [18F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[57] G. Cheon,et al. Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study , 2013, Nuclear Medicine and Molecular Imaging.
[58] C. Geppert,et al. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. , 2013, AJR. American journal of roentgenology.
[59] T. Holland-Letz,et al. Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[60] C. Geppert,et al. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. , 2013, Radiology.
[61] R. Dierckx,et al. The Use of 18F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases , 2013, Clinical & developmental immunology.
[62] J. Vercher-Conejero,et al. PET/MRI: Applications in Clinical Imaging , 2013, Current Radiology Reports.
[63] Torsten Kuwert,et al. Systematic Evaluation of Phantom Fluids for Simultaneous PET/MR Hybrid Imaging , 2013, The Journal of Nuclear Medicine.
[64] M. Forsting,et al. Correlation of the Apparent Diffusion Coefficient (ADC) with the Standardized Uptake Value (SUV) in Hybrid 18F-FDG PET/MRI in Non-Small Cell Lung Cancer (NSCLC) Lesions: Initial Results , 2013, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.
[65] A. Haug,et al. 68Ga-DOTATATE PET/CT in the pre-surgical staging of ileal and pancreatic neuroendocrine tumors: Correlation with histopathology and impact on surgical management , 2013 .
[66] C. Claussen,et al. Correlation of Simultaneously Acquired Diffusion-Weighted Imaging and 2-Deoxy-[18F] fluoro-2-D-glucose Positron Emission Tomography of Pulmonary Lesions in a Dedicated Whole-Body Magnetic Resonance/Positron Emission Tomography System , 2013, Investigative radiology.
[67] A. Alavi,et al. PET/MR imaging: technical aspects and potential clinical applications. , 2013, Radiology.
[68] H. Jadvar. Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[69] Sheung Tat Fan,et al. 11C-Acetate and 18F-FDG PET/CT for Clinical Staging and Selection of Patients with Hepatocellular Carcinoma for Liver Transplantation on the Basis of Milan Criteria: Surgeon’s Perspective , 2013, The Journal of Nuclear Medicine.
[70] Colin Studholme,et al. Interictal PET and ictal subtraction SPECT: Sensitivity in the detection of seizure foci in patients with medically intractable epilepsy , 2013, Epilepsia.
[71] T. Holland-Letz,et al. PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[72] T. Derlin,et al. Comparative diagnostic performance of 18F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation , 2013, European Radiology.
[73] E. Zamagni,et al. The role of imaging techniques in the management of multiple myeloma , 2012, British journal of haematology.
[74] S. Thiruvenkadam,et al. Comparison of 4-class and continuous fat/water methods for whole-body, MR-based PET attenuation correction , 2012, 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC).
[75] Michael Laniado,et al. PET/MRI in head and neck cancer: initial experience , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[76] H. Zhuang,et al. PET/CT in Patients with Sarcoidosis or IgG4 Disease. , 2012, PET clinics.
[77] G. Fink,et al. Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[78] Kevin Petrecca,et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.
[79] Kenji Hirata,et al. 18F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[80] C. Boy,et al. 68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors , 2011, The Journal of Nuclear Medicine.
[81] Gina Brown,et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] S. Majumdar,et al. Ultrashort echo time MRI of cortical bone at 7 tesla field strength: A feasibility study , 2011, Journal of magnetic resonance imaging : JMRI.
[83] James M. Mountz,et al. SPECT Imaging of Epilepsy: An Overview and Comparison with F-18 FDG PET , 2011, International journal of molecular imaging.
[84] Yousef Mazaheri,et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.
[85] Alberto Pupi,et al. PET/CT in diagnosis of dementia , 2011, Annals of the New York Academy of Sciences.
[86] Alimuddin Zumla,et al. Combined PET and X-ray computed tomography imaging in pulmonary infections and inflammation , 2011, Current opinion in pulmonary medicine.
[87] T. Takahara,et al. Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with 18F-FDG PET/CT. , 2011, AJR. American journal of roentgenology.
[88] W. Curran,et al. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. , 2009, International journal of radiation oncology, biology, physics.
[89] U. Tateishi,et al. The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level , 2011, Annals of nuclear medicine.
[90] Mark Bydder,et al. Qualitative and quantitative ultrashort echo time (UTE) imaging of cortical bone. , 2010, Journal of magnetic resonance.
[91] Jeffry S Nyman,et al. Characterization of 1H NMR signal in human cortical bone for magnetic resonance imaging , 2010, Magnetic resonance in medicine.
[92] Paul E Kinahan,et al. Variability in PET quantitation within a multicenter consortium. , 2010, Medical physics.
[93] A. Crucitti,et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. , 2010, Radiographics.
[94] R. Tishler,et al. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[95] Satoshi Goshima,et al. Preoperative detection of prostate cancer: A comparison with 11C‐choline PET, 18F‐fluorodeoxyglucose PET and MR imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[96] T. Borght,et al. Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma , 2010, Acta oncologica.
[97] P. Lambin,et al. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation. , 2010, European journal of cancer.
[98] J. Bruzzi,et al. Clinical utility of PET/CT in lymphoma. , 2010, AJR. American journal of roentgenology.
[99] M. Chamberlain. Radiographic patterns of relapse in glioblastoma , 2010, Journal of Neuro-Oncology.
[100] F. Kee,et al. The value of positron emission tomography in patients with non-small cell lung cancer. , 2010, European journal of radiology.
[101] Hiroki Kato,et al. Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography , 2010, Japanese Journal of Radiology.
[102] F. Fazio,et al. Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis. , 2009, European journal of cancer care.
[103] N. Ferris,et al. Preoperative staging of rectal cancer. , 2009, Future oncology.
[104] Martin Hutchings,et al. PET/CT for Therapy Response Assessment in Lymphoma , 2009, Journal of Nuclear Medicine.
[105] Pek-Lan Khong,et al. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. , 2009, Radiology.
[106] Janet F. Eary,et al. NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies , 2009, Molecular Imaging and Biology.
[107] S. Goldman,et al. POSITRON EMISSION TOMOGRAPHY‐GUIDED VOLUMETRIC RESECTION OF SUPRATENTORIAL HIGH‐GRADE GLIOMAS: A SURVIVAL ANALYSIS IN 66 CONSECUTIVE PATIENTS , 2009, Neurosurgery.
[108] T. Chen,et al. The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma. , 2009, Academic radiology.
[109] R Sankar,et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy , 2008, Neurology.
[110] B. O'neill,et al. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. , 2007, The Lancet. Oncology.
[111] Klemens Scheidhauer,et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[112] P. Maisonneuve,et al. Carcinoma of the cervix uteri , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[113] G. Mathern,et al. FDG‐PET/MRI Coregistration and Diffusion‐Tensor Imaging Distinguish Epileptogenic Tubers and Cortex in Patients with Tuberous Sclerosis Complex: A Preliminary Report , 2006, Epilepsia.
[114] Wei Chen,et al. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[115] P. Maisonneuve,et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[116] Rodney J Hicks,et al. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[117] F. Guillemin,et al. Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[118] Sibylle Ziegler,et al. PET/CT: challenge for nuclear cardiology. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[119] A. Bernard,et al. Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule , 2005, The European Journal of Health Economics.
[120] M. Mathews,et al. Cost-Effectiveness of Positron Emission Tomography in Breast Cancer , 2005, Molecular Imaging and Biology.
[121] D. Matchar,et al. FDG-PET for management of cervical and ovarian cancer. , 2005, Gynecologic oncology.
[122] A H Kaye,et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. , 2004, Brain : a journal of neurology.
[123] G Lucignani,et al. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective , 2004, Nuclear medicine communications.
[124] S. Larson,et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. , 2004, Journal of the American College of Surgeons.
[125] J. Tropp,et al. Image brightening in samples of high dielectric constant. , 2004, Journal of magnetic resonance.
[126] M. Frydenberg,et al. Investigations with FDG-PET Scanning in Prostate Cancer Show Limited Value for Clinical Practice , 2002, Acta oncologica.
[127] O. Dworak. Morphology of lymph nodes in the resected rectum of patients with rectal carcinoma. , 1991, Pathology, research and practice.
[128] A. Friedman,et al. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography , 1991, Annals of neurology.
[129] W P Dillon,et al. Radiation injury of the brain. , 1991, AJNR. American journal of neuroradiology.